logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Mehmet Asım Bilen

Winship Cancer Institute of Emory University

49H指数
663论文数
1.2W被引数
收录论文 158
发表时间
logo
Association between smoking, tumor genetics, and outcomes in men with metastatic prostate cancer吸烟、肿瘤遗传学与转移性前列腺癌患者预后的关联
errProstate Cancer and Prostatic Diseases
IF5.8
err2026-09-05
err0
PREAI
errChristopher Choi; Matthew Labriola; Nicholas Henderson; Alec Chu; Clara Hwang; Pedro C. Barata; Frank Cameron Cackowski; Amanda Broderick; Rana R. McKay; Mehmet Asim Bilen; Deepak Kilari; Laura S. Graham; Abhishek Tripathi; Rohan Garje; Vadim S. Koshkin; Tanya B. Dorff; Michael Thomas Schweizer; Zachery R. Reichert; Alexandra O. Sokolova; Catherine H. Marshall; Andrew J. Armstrong
err分享
err收藏
A Stromal–Immune computational pathology Signature for prognosis and immune checkpoint inhibitor Response in localized, locally advanced and metastatic urothelial carcinoma: A Multicenter retrospective Study基质–免疫计算病理学标志物在局部、局部晚期和转移性尿路上皮癌中的预后预测及免疫检查点抑制剂应答评价：一项多中心回顾性研究
errEuropean Journal of Cancer
IF7.1
err2026-08-07
err0
errOAAI
errBolin Song; Himanshu Maurya; Tianyi Xia; Naoto Tokuyama; Kamal Hammouda; Xiangxue Wang; Ibrahim Mohammad; Tilak Pathak; Xiuming Zhang; Viraj A. Master; Mehmet Asim Bilen; Shilpa Gupta; Cheng Lu; Hexiang Wang; Anant Madabhushi
err分享
err收藏
Real-world comparative effectiveness of apalutamide versus enzalutamide for prostate-specific antigen response in metastatic castration-sensitive prostate cancer阿帕卢他胺与恩扎卢他胺在转移性去势敏感前列腺癌中前列腺特异性抗原反应的实世界比较有效性
errTherapeutic Advances in Medical Oncology
IF4.2
err2026-05-21
err0
PREAI
errMehmet A. Bilen; Benjamin H. Lowentritt; Sabree Burbage; Charmi Patel; Carmine Rossi; Frederic Kinkead; Gordon Wong; Dominic Pilon; Neal D. Shore
err分享
err收藏
Inflammatory biomarkers have a prognostic role in patients with metastatic castration-resistant prostate cancer treated with Lutetium-177–PSMA-617炎症生物标志物在用177Lu–PSMA-617治疗的患者中具有预后作用
errCancer
IF5.1
err2026-04-16
err0
PREAI
errMargo B. Gerke BA; Angelo Marra MPH; Yuan Liu PhD; Akshay Bedmutha MD; Jacqueline T. Brown MD; Bassel Nazha MD; Jacob E. Berchuck MD; Ravi Bharat Parikh MD; Shahid Ahmed MD; Jordan Alana Ciuro MD; Caitlin Hartman FNP; Greta Russler McClintock FNP; Sarah Caulfield PharmD; Omer Kucuk MD; Bradley Curtis Carthon MD, PhD; David M. Schuster MD; Saima Muzahir MD; Mehmet Asim Bilen MD
err分享
err收藏
Case Report: Looks can deceive: acute postoperative progressive renal dysfunction and hyperkalemia without significant hydronephrosis
errFrontiers in Oncology
IF3.3
err2026-01-30
err0
errOAAI
errReza Lahiji†; Ahmet Yildirim†; William Luke; Lorenzo Storino Ramacciotti; Ernest A. Morton; Talia Avigail Helman; Jocelyn Nguyen; Valentina Grajales; Shreyas S. Joshi; Vikram M. Narayan; Behnam Nabavizadeh; Mohammad Hajiha; Reza Nabavizadeh; Peter J. Park; Kenneth Ogan; Mehmet A. Bilen; Viraj A. Master
err分享
err收藏
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers高级泌尿肿瘤共识会议（AUC3）2025：肾细胞癌和尿路肿瘤管理的专家共识
errCA: A Cancer Journal for Clinicians
IF0
err2025-12-13
err0
errOAAI
errRana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
err分享
err收藏
Overcoming resistance in advanced urothelial carcinoma: mechanisms of escape from antibody-drug conjugates and FGFR3 inhibition克服晚期尿路上皮癌的耐药性：逃避抗体药物偶联物和FGFR3抑制的机制
errFrontiers in Oncology
IF3.3
err2025-12-02
err0
errOAAI
errBrandon Wummer; Michael Schwartz; Jordan Ciuro; Shahid Ahmed; Shreyas S. Joshi; Vikram M. Narayan; Bradley C. Carthon; Mehmet Asim Bilen; Jacqueline T. Brown
err分享
err收藏
Response to Letter to the Editor Regarding: ‘Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'对关于“在转移性去势敏感型前列腺癌中阿帕鲁他胺对比恩扎鲁他胺的总生存期”的读者来信的回复
errAdvances in Therapy
IF4
err2025-11-28
err0
errOAAI
errMehmet A. Bilen; Benjamin Lowentritt; Ibrahim Khilfeh; Carmine Rossi; Shawn Du; Frederic Kinkead; Lilian Diaz; Dominic Pilon; Lorie Ellis; Neal D. Shore
err分享
err收藏
Targeting p300 and CBP abolishes HOXB13-loss-induced lipogenesis and tumor metastasis靶向p300和CBP消除了HOXB13缺失诱导的脂生成和肿瘤转移
errJCI INSIGHT
IF6.1
err2025-11-24
err0
PREAI
errLu, Xiaodong; Peng, Liu; Chu, Qi; Ye, Samantha; Liu, Mingyang; Hussain, Maha; Bilen, Mehmet A.; Harik, Lara R.; Melamed, Jonathan; Zhao, Jonathan C.; Yu, Jindan
err分享
err收藏
Phase 2 Study of Perioperative Lenvatinib with Pembrolizumab in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
errJOURNAL OF IMMUNOLOGY
IF3.4
err2025-11-01
err0
PREAI
errDavey, Paris; Vo, BaoHan; Bilen, Mehmet; Liu, Yuan; Davarpanahfakhr, Amir; Nazha, Bassel; Brown, Jacqueline; Osunkoya, Adeboye; Williams, Sierra; Session, Wilena; Hartman, Caitlin; Russler, Greta; Caulfield, Sarah; Joshi, Shreyas; Narayan, Vikram; Ogan, Kenneth; Kucuk, Omer; Carthon, Bradley; Boyanton, Adriana; Master, Viraj; Kissick, Haydn
err分享
err收藏
Genomic alterations and associated outcomes in patients with PSMA-positive metastatic castration-resistant prostate cancer treated with 177Lu-PSMA-617PSMA阳性转移性去势抵抗性前列腺癌患者接受177Lu-PSMA-617治疗后的基因组改变及关联结局
errONCOLOGIST
IF4.2
err2025-11-01
err0
PREAI
errPanian, Justine; Henderson, Nicholas C.; Herchenhorn, Daniel; Barata, Pedro C.; Bilen, Mehmet Asim; Graham, Laura; Heath, Elisabeth; Hwang, Clara; Supernois, Avery; Kilari, Deepak; Thapa, Bicky; Koshkin, Vadim S.; Jindal, Tanya; Nauseef, Jones T.; Sokolova, Alexandra; Amery, Taylor; Zakharia, Yousef; Schweizer, Michael T.; Raychaudhuri, Ruben; Reichert, Zachery R.; Dorff, Tanya; Armstrong, Andrew J.; Wang, John; Alva, Ajjai; Mckay, Rana R.
err分享
err收藏
Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma
errJOURNAL OF IMMUNOLOGY
IF3.4
err2025-11-01
err0
PREAI
errWirth, Lena Vanessa; Hugaboom, Miya B.; Street, Kelly; Ruthen, Neil; Jegede, Opeyemi; Schindler, Nicholas; Shah, Valisha; Zaemes, Jacob; El Ahmar, Nourhan; Matar, Sayed; Savla, Varunika; Choueiri, Toni; Denize, Thomas; West, Destiny; Mcdermott, David F.; Plimack, Elizabeth R.; Sosman, Jeffrey; Haas, Naomi; Hurwitz, Michael E.; Hammers, Hans; Stein, Mark; Alter, Robert; Bilen, Mehmet; Signoretti, Sabina; Atkins, Michael B.; Wu, Catherine J.; Braun, David
err分享
err收藏
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative studyFGFR3突变型晚期尿路上皮癌中，erdafitinib在enfortumab vedotin治疗前或治疗后的疗效：UNITE协作研究的分析
errONCOLOGIST
IF4.2
err2025-11-01
err0
PREAI
errJiang, Cindy Y.; Hwang, Hyunsoo; Epstein, Ilana Y.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Taylor, Amy K.; Nizam, Amanda; Jindal, Tanya; Glover, Michael J.; Khaki, Ali Raza; Barata, Pedro C.; Nguyen, Charles B.; Oh, Eugene; Davis, Nancy B.; Mabey, Hannah; Hoimes, Christopher J.; Evans, Sean T.; Abuqayas, Bashar; Lemke, Emily; Tsung, Irene; Qiao, Wei; Kilari, Deepak; Zakharia, Yousef; Bilen, Mehmet A.; Milowsky, Matthew, I; Shah, Sumit A.; Gupta, Shilpa; Emamekhoo, Hamid; Bellmunt, Joaquim; Alva, Ajjai S.; Grivas, Petros; Msaouel, Pavlos; Koshkin, Vadim S.; Campbell, Matthew T.; Alhalabi, Omar
err分享
err收藏
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study接受恩沃利单抗维多汀治疗的晚期尿路上皮癌患者中的治疗相关不良事件及关联结局：UNITE研究的分析
errCANCER MEDICINE
IF3.1
err2025-10-02
err0
errOAAI
errNizam, Amanda; Nguyen, Charles B.; Li, Jinju; Zabor, Emily C.; Msaouel, Pavlos; Jiang, Cindy Y.; Alhalabi, Omar; Oh, Eugene; Davidsohn, Matthew P.; Epstein, Ilana B.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Jindal, Tanya; Taylor, Amy K.; Glover, Michael J.; Khaki, Ali Raza; Lemke, Emily; Mabey, Hannah; Abuqayas, Bashar; Jang, Albert; Brown, Jason R.; Evans, Sean T.; Pywell, Cameron; Basu, Arnab; Bilen, Mehmet A.; Barata, Pedro C.; Zakharia, Yousef; Milowsky, Matthew I.; Kilari, Deepak; Hoimes, Christopher J.; Shah, Sumit A.; Emamekhoo, Hamid; Davis, Nancy B.; Gupta, Shilpa; Grivas, Petros; Bellmunt, Joaquim; Campbell, Matthew T.; Alva, Ajjai S.; Koshkin, Vadim S.
err分享
err收藏
A Phase 1, multiple-dose study to evaluate the safety and tolerability of first-in-class XmAb819 (ENPP3 x CD3) in subjects with relapsed or refractory clear cell renal cell carcinoma (ccRCC) (NCT05433)一项I期、多次给药研究，旨在评估首创新药XmAb819 (ENPP3 x CD3)在复发或难治性透明细胞肾细胞癌（ccRCC）受试者中的安全性与耐受性（NCT05433）。
errONCOLOGIST
IF4.2
err2025-10-01
err0
errOAAI
errBohac, Chet; Pal, Sumanta; Sweis, Randy; Kotecha, Ritesh; Runcie, Karie; Bilen, Mehmet; Braun, David; Tykodi, Scott; Hoimes, Christopher; Suri, Vithika; Kanodia, Jitendra; Salama, Engie; Woo, Jacky; Li, Lingling; Yang, Yuanquan; Franklin, Robert; Maly, Joseph; Grigg, Claud; Gulati, Shuchi; Vanderweele, David J.; Garmezy, Benjamin
err分享
err收藏
CD163+Tumor-Associated macrophages and clinical outcomes to First-Line nivolumab therapy in patients with metastatic clear cel renal cell carcinoma: insights from the HCRN GU16-260 trialCD163+肿瘤相关巨噬细胞与转移性透明细胞肾细胞癌患者接受一线纳武利尤单抗治疗的临床结局：来自HCRN GU16-260试验的见解
errONCOLOGIST
IF4.2
err2025-10-01
err0
errOAAI
errSimsek, Berkay; Paul, Morgan A.; Xie, Wanling; El Ahmar, Nourhan; Matar, Sayed; Laimon, Yasmin Nabil; RobertiDe Oliveira, Gabriel; Mohanna, Razan; Delcea, Andrew; Choueri, Toni; Braun, David; Sun, Maxine; Haas, Naomi B.; Hammers, Hans J.; Bilen, Mehmet; Stein, Mark N.; Sosman, Jeffrey A.; Freeman, Gordon J.; Wu, Catherine; Mcdermott, David; Atkins, Michael B.; Signoretti, Sabina
err分享
err收藏
Impact of treatment patterns and sequencing on clinical and economic outcomes in patients with metastatic urothelial cancer: IMPACT UC II study治疗模式及顺序对患者转移性尿路上皮癌临床和经济结局的影响：IMPACT UC II研究
errONCOLOGIST
IF4.2
err2025-10-01
err0
errOAAI
errBilen, Mehmet A.; Diessner, Brandon; White, John; Murphy, Louise; Nguyen, Amy; Kirker, Melissa; Gharibian, Norbek; Morris, Valerie; Bhanegaonkar, Abhijeet
err分享
err收藏
Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma三级淋巴结构的存在和耗竭性组织驻留T细胞决定了肾细胞癌对PD-1阻断的临床反应
errONCOLOGIST
IF4.2
err2025-10-01
err0
errOAAI
errWirth, Lena; Hugaboom, Miya; Street, Kelly; Ruthen, Neil; Jegede, Opeyemi; Schindler, Nicholas; Shah, Valisha; Zaemes, Jacob; El Ahmar, Nourhan; Matar, Sayed; Savla, Varunika; Choueri, Toni; Denize, Thomas; West, Destiny; Mcdermott, David; Plimack, Elizabeth; Sosman, Jeffrey A.; Haas, Naomi B.; Hurwitz, Michael; Hammers, Hans J.; Stein, Mark N.; Alter, Robert; Bilen, Mehmet; Signoretti, Sabina; Atkins, Michael B.; Wu, Catherine; Braun, David
err分享
err收藏
Phase I study of palbociclib with cisplatin or carboplatin in the management of patients with advanced pancreatic cancer帕博西利与顺铂或卡铂联合治疗晚期胰腺癌的I期研究
errONCOLOGIST
IF4.2
err2025-10-01
err0
errOAAI
errAlese, Olatunji B.; Harvey, Robert Donald; Wu, Christina; Hitron, Elise; Collins, Hannah; Scott, Suzanne; Steuer, Conor; Bilen, Mehmet A.; Carthon, Bradley C.; Switchenko, Jeffrey M.; Ramalingam, Suresh S.; Owonikoko, Taofeek K.
err分享
err收藏
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study恩福妥单抗（Enfortumab Vedotin）在具有不同组织学亚型的晚期尿路上皮癌患者中的疗效：UNITE研究的分析
errEuropean Urology
IF25.2
err2025-09-14
err0
PREAI
errTanya Jindal; Cindy Y. Jiang; Omar Alhalabi; Charles B. Nguyen; Eugene Oh; Irene Tsung; Dimitra Rafailia Bakaloudi; Rafee Talukder; Matthew Davidsohn; Dory Freeman; Ilana Y. Epstein; Chien-Kuang Cornelia Ding; Amanda Nizam; Michael J. Glover; Ali Raza Khaki; Amy K. Taylor; Emily Lemke; Albert Jang; Sean T. Evans; Denny Shin; Cameron Pywell; Arnab Basu; Mehmet A. Bilen; Yousef Zakharia; Pedro Barata; Matthew I. Milowsky; Jason Brown; Deepak Kilari; Hamid Emamekhoo; Christopher J. Hoimes; Sumit Shah; Nancy B. Davis; Shilpa Gupta; Petros Grivas; Joaquim Bellmunt; Ajjai Alva; Matthew T. Campbell; Vadim S. Koshkin
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
M
M. Hassan Murad
H 指数: 184 · 论文数: 1.4K
G
Gordon J. Freeman
H 指数: 174 · 论文数: 1.1K
S
Stephen J. Chanock
H 指数: 170 · 论文数: 2.2K
T
Toni K. Choueiri
H 指数: 149 · 论文数: 2.4K
R
Robert J. Motzer
H 指数: 148 · 论文数: 1.6K
查看更多